Exact Sciences
EXAS
#1703
Rank
HK$77.54 B
Marketcap
HK$419.01
Share price
1.42%
Change (1 day)
-17.49%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total debt

Total debt on the balance sheet as of September 2024 : HK$21.47 Billion

According to Exact Sciences's latest financial reports the company's total debt is HK$21.47 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Exact Sciences - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31HK$19.95 B4.37%
2022-12-31HK$19.11 B2.93%
2021-12-31HK$18.57 B2.81%
2020-12-31HK$18.06 B142.91%
2019-12-31HK$7.43 B37.8%
2018-12-31HK$5.39 B15420.88%
2017-12-31HK$34.77 M-18.36%
2016-12-31HK$42.59 M-8.65%
2015-12-31HK$46.62 M102.14%
2014-12-31HK$23.06 M-31.86%
2013-12-31HK$33.85 M113.69%
2012-12-31HK$15.84 M103.99%
2011-12-31HK$7.76 M-0.2%
2010-12-31HK$7.78 M-49.51%
2009-12-31HK$15.41 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
HK$1.11 B-94.80%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.15 B-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$90.23 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$198.20 B 823.03%๐Ÿ‡ซ๐Ÿ‡ท France